In a case reported by Jang et al., a 6-year-old girl diagnosed with anti-LGI1 encephalitis who did not respond to first-line immunotherapy and RTX treatment experienced significant improvements in FBDSs and cognitive symptoms after being treated with TCZ [66]. The gene discussed is LGI1; the disease is encephalitis.